About Us



OUR HISTORY

The Ethos started its activities for more than twenty years with two arms of operation, the assistance and the medical / scientific support for academia and the private sector, primarily the pharmaceutical industry.

Always had as mission, ethical provide medical services using innovative, collaborative tools.

His team has always been multidisciplinary and is based on the collaborative innovation. This fact has meant that we now have employees and partners in Brazil and in the world with high academic standards and technical. linked to universities and other public and private institutions.

The experience of its founder and CEO, Dr. Hilton Oliveira dos Santos Filho, PhD, goal all activities developed by our company.
Providing services ethically using innovative strategies focusing on the result, it is the Innovation Ethos differential in Medical Services.

Provide medical consulting services with ethics, using innovative strategies to focus on results.

To be among the best companies to provide medical services in the next five years. To be recognized by the market as one of the most solid and effective companies in conducting services with innovative strategies.

• Focus on customer needs;
• Continuous improvement processes;
• Commitment to goals, deadlines and quality of our services;
• Continuous improvement in innovative customer-focused strategies;
• Continuous search partners, consultants and national and international partnerships aligned to our vision;
• Ethics and innovative, collaborative strategic solutions;

Dr. Hilton Oliveira dos Santos Filho, PhD (Diretor clínico e CEO)

Hilton
Physician with 20 years of experience in the pharmaceutical industry. Medical support and scientific support for marketing activities, scientific documentation, clinical trials, consultancy and services in Pharmacovigilance / “drug safety”, P & ID, planning and design of bioavailability, bioequivalence, pharmacoepidemiology, pharmacogenetics, Clinical Studies phase I – IV clinical and academic studies (bioequivalence and clinical phase I study).

Critical Analysis of the medical literature, particularly for R & DI, expertise in clinical research, drug safety and risk management.

Experience in managing R & D projects, from conception to the registration of the drug. Performed this procedure on several projects of incremental and radical innovation, assessing the risks and impacts of the project.